Quinolinesulfonamides of Aryloxy‐/Arylthio‐ethyl Piperidines: Influence of an Arylether Fragment on 5‐HT1A/5‐HT7 Receptor Selectivity
Medienart: |
Artikel |
---|
Erscheinungsjahr: |
2013 |
---|---|
Erschienen: |
2013 |
Enthalten in: |
Zur Gesamtaufnahme - volume:346 |
---|---|
Enthalten in: |
Archiv der Pharmazie - 346(2013), 3 vom: März, Seite 180-188 |
Beteiligte Personen: |
Grychowska, Katarzyna [VerfasserIn] |
---|
BKL: |
---|
Umfang: |
9 |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
OLC1914377907 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | OLC1914377907 | ||
003 | DE-627 | ||
005 | 20230713164553.0 | ||
007 | tu | ||
008 | 130315s2013 xx ||||| 00| ||und c | ||
028 | 5 | 2 | |a sw130314_1 |
035 | |a (DE-627)OLC1914377907 | ||
035 | |a (DE-599)GBVOLC1914377907 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
082 | 0 | 4 | |a 610 |q AVZ |
084 | |a PHARM |2 fid | ||
084 | |a 44.40 |2 bkl | ||
100 | 1 | |a Grychowska, Katarzyna |e verfasserin |4 aut | |
245 | 1 | 0 | |a Quinolinesulfonamides of Aryloxy‐/Arylthio‐ethyl Piperidines: Influence of an Arylether Fragment on 5‐HT1A/5‐HT7 Receptor Selectivity |
264 | 1 | |c 2013 | |
300 | |a 9 | ||
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
338 | |a Band |b nc |2 rdacarrier | ||
700 | 1 | |a Marciniec, Krzysztof |4 oth | |
700 | 1 | |a Canale, Vittorio |4 oth | |
700 | 1 | |a Szymiec, Michał |4 oth | |
700 | 1 | |a Glanowski, Grzegorz |4 oth | |
700 | 1 | |a Satała, Grzegorz |4 oth | |
700 | 1 | |a Maślankiewicz, Andrzej |4 oth | |
700 | 1 | |a Pawłowski, Maciej |4 oth | |
700 | 1 | |a Bojarski, Andrzej J. |4 oth | |
700 | 1 | |a Zajdel, Paweł |4 oth | |
773 | 0 | 8 | |i Enthalten in |t Archiv der Pharmazie |d Weinheim : Wiley-Blackwell, 1835 |g 346(2013), 3 vom: März, Seite 180-188 |w (DE-627)129090786 |w (DE-600)6381-2 |w (DE-576)014425955 |x 0365-6233 |7 nnns |
773 | 1 | 8 | |g volume:346 |g year:2013 |g number:3 |g month:03 |g pages:180-188 |g extent:9 |
912 | |a GBV_USEFLAG_A | ||
912 | |a SYSFLAG_A | ||
912 | |a GBV_OLC | ||
912 | |a FID-PHARM | ||
912 | |a SSG-OLC-CHE | ||
912 | |a SSG-OLC-PHA | ||
912 | |a SSG-OLC-DE-84 | ||
912 | |a SSG-OPC-PHA | ||
912 | |a GBV_ILN_20 | ||
912 | |a GBV_ILN_24 | ||
912 | |a GBV_ILN_65 | ||
912 | |a GBV_ILN_69 | ||
912 | |a GBV_ILN_123 | ||
912 | |a GBV_ILN_267 | ||
912 | |a GBV_ILN_2018 | ||
912 | |a GBV_ILN_2157 | ||
912 | |a GBV_ILN_4012 | ||
912 | |a GBV_ILN_4277 | ||
912 | |a GBV_ILN_4306 | ||
936 | b | k | |a 44.40 |q AVZ |
951 | |a AR | ||
952 | |d 346 |j 2013 |e 3 |c 3 |h 180-188 |g 9 |